Epidemiological studies suggest that the risk of developing cognitive impairment and dementia is increased in individuals with diabetes mellitus, although the evidence from clinicopathological studies on neurodegenerative changes is at odds with these observations. A thorough appraisal of concomitant vascular changes in dementia might resolve this incongruity.
References
Sonnen, J. A. et al. Different patterns of cerebral injury in dementia with or without diabetes. Arch. Neurol. 66, 315–322 (2009).
Xu, W. L., von Strauss, E., Qiu, C. X., Winblad, B. & Fratiglioni, L. Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia doi: 10.1007/s00125-009-1323-x.
Alafuzoff, I., Aho, L., Helisalmi, S., Mannermaa, A. & Soininen, H. β-Amyloid deposition in brains of subjects with diabetes. Neuropathol. Appl. Neurobiol. 35, 60–68 (2009).
Kalaria, R. N. et al. Towards defining the neuropathological substrates of vascular dementia. J. Neurol. Sci. 226, 75–80 (2004).
van Harten, B., de Leeuw, F. E., Weinstein, H. C., Scheltens, P. & Biessels, G. J. Brain imaging in patients with diabetes: a systematic review. Diabetes Care 29, 2539–2548 (2006).
Beeri, M. S. et al. Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. Neurology 71, 750–757 (2008).
Arvanitakis, Z. et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 67, 1960–1965 (2006).
Peila, R., Rodriguez, B. L. & Launer, L. J. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51, 1256–1262 (2002).
Wilcock, D. M. & Colton, C. A. Anti-Aβ immunotherapy in Alzheimer's disease: relevance of transgenic mouse studies to clinical trials. J. Alzheimers Dis. 15, 555–569 (2008).
Nelson, P. T. et al. Human cerebral neuropathology of type 2 diabetes mellitus. Biochim. Biophys. Acta 1792, 454–469 (2008).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Kalaria, R. Diabetes, microvascular pathology and Alzheimer disease. Nat Rev Neurol 5, 305–306 (2009). https://doi.org/10.1038/nrneurol.2009.72
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2009.72
- Springer Nature Limited
This article is cited by
-
Confronting racially exclusionary practices in the acquisition and analyses of neuroimaging data
Nature Neuroscience (2023)
-
Protective effect of lactoferrin administration against brain tissue damage in diabetic rats
Journal of Umm Al-Qura University for Applied Sciences (2023)
-
Deep spectral learning for label-free optical imaging oximetry with uncertainty quantification
Light: Science & Applications (2019)
-
Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with excisting diabetic drugs
Journal of Diabetes & Metabolic Disorders (2019)
-
Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin
Acta Neuropathologica Communications (2018)